Description
An anti-peptic ulcer drug is a class
of drugs used for the treatment of most common ulcers in stomach and upper part
of small intestine. These drugs act by decreasing the levels of gastric acidity
or by enhancing the protection for mucosa. Major causes of peptic ulcer are
Helicobacter pylori (H. pylori) infection or due to long-term use of drugs such
as aspirin, ibuprofen and non-steroidal anti-inflammatory drugs (NSAIDs).
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/anti-peptic-ulcer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Anti-peptic ulcer drugs market is
classified based on:
- Drug class
- Proton pump inhibitor
- H2 receptor antagonist
- Gastric mucosal protective drugs
- Antacid
- Antibiotics
- Others
At present, North America dominates
the global anti-peptic ulcer drugs market and is followed by Europe.
Anti-peptic ulcer drugs market growth in these regions is attributed to high
incidence of people suffering from peptic ulcers and large number of patents
expected to expire and thereby allowing entry of generics. Developing nations
of Latin America such as Brazil, Argentina and Chile as well as Middle East
Asian countries are expected to show rapid growth in demand for anti-peptic
ulcer drugs due to poor sanitization and hygienic practices causing H. pylori
infections in these regions. Higher incidence of peptic acid ulcers is boosting
the production and marketing of anti-peptic ulcer drugs in Asia-Pacific regions
such as India, China, and Australia.
Some of the key factors driving the
market for anti-peptic ulcer drugs are increase in patient pool with H. pylori
infection, stressed lifestyles, advances in peptic ulcer therapies and patent
exclusivity expiration leading to decline in revenues and the resultant high
generic competition.
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment